The Generic Drug Industry Embraces a Faster, Cheaper Pathway for Challenging Patents

ConclusionIn the pharmaceutical market, the inter partes review process can meaningfully contribute to ensuring that invalid patents do not block timely availability of generic drugs.
Source: Applied Health Economics and Health Policy - Category: Health Management Source Type: research